Veracyte: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits

Item 2.02. Results of Operations and Financial Condition.On November 4, 2026, Veracyte, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report.The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.Item 8.01. Other Events.On November 4, 2026, the Company announced the commencement of a share repurchase program previously authorized by the Board of Directors of the Company, pursuant to which the Company may repurchase up to $100.0 million of its outstanding common stock during the one-year period beginning on the date of the public announcement of the program (the “Repurchase Program”). Repurchases under the Repurchase Program may be made from time to time in open-market transactions, including in accordance with Rule 10b-18 under the Exchange Act or pursuant to trading plans adopted in accordance with Rule 10b5-1 under the Exchange Act, privately negotiated transactions, accelerated share repurchase transactions or other transactions, in each case in accordance with applicable laws and regulations.The timing, amount and terms of any repurchases will depend on a variety of factors, including market conditions, the trading price of the Company’s common stock, the Company’s financial position and results of operations, capital requirements, general business conditions, alternative investment opportunities and other factors the Company deems relevant. The Repurchase Program does not obligate the Company to repurchase any specific number of shares and may be modified, suspended or discontinued at any time without prior notice at the Company’s discretion.Item 9.01 Financial Statements and Exhibits. (d) Exhibits.Exhibit No.Description99.1Press release issued by Veracyte, Inc. dated November 4, 2026.104Cover Page Interactive Data File (embedded within the Inline XBRL document).SIGNATUREPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.Dated:November 4, 2026VERACYTE, INC.By:/s/ Rebecca ChambersName:Rebecca ChambersTitle:Chief Financial OfficerPrincipal Financial Officer

Veracyte: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits

Інші новини компанії